comparemela.com
Home
Live Updates
Portage Biotech Shares Rise 20% After Keytruda Deal With Merck : comparemela.com
Portage Biotech Shares Rise 20% After Keytruda Deal With Merck
By Chris Wack Portage Biotech shares were up 20% to $2.81 after the company entered into a clinical trial collaboration agreement with Merck to evaluate...
Related Keywords
Ian Walters ,
Chris Wack ,
,
Portage Biotech ,
Article Normal ,
Biotechnology Services ,
Pharmaceuticals ,
Healthcare Life Sciences ,
Financial Performance ,
Share Price Movement Disruptions ,
Ownership Changes ,
Acquisitions Mergers Shareholdings ,
New Products Services ,
Research Development ,
Corporate Actions ,
Corporate Industrial News ,
Products Services ,
New Product Service Testing ,
Biology ,
Biotechnology ,
Political General News ,
Sciences Humanities ,
Equity Markets ,
Commodity Financial Market News ,
Content Types ,
Factiva Filters ,
C Amp Ampe Exclusion Filter ,
C Amp Ampe Industry News Filter ,
Synd ,
Prtg ,
Share Price Movement ,
Disruptions ,
Acquisitions ,
Mergers ,
Shareholdings ,
New Products ,
Services ,
Research ,
Development ,
Corporate ,
Industrial News ,
Products ,
New Product ,
Service Testing ,
Political ,
General News ,
Sciences ,
Humanities ,
Commodity ,
Financial Market News ,
Healthcare ,
Life Sciences ,
comparemela.com © 2020. All Rights Reserved.